Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2023-06-23 Purchase |
2023-06-26 4:34 pm |
DiaMedica Therapeutics Inc. | DMAC | Pauls Dietrich John President and CEO |
12,787 | $3.91 | $49,997 | 68,591 (Direct) |
View |
| 2022-11-16 Purchase |
2022-11-16 8:56 pm |
DiaMedica Therapeutics Inc. | DMAX | Pauls Dietrich John President and CEO |
20,000 | $1.21 | $24,200 | 55,804 (Direct) |
View |
| 2021-08-16 Purchase |
2021-08-16 4:19 pm |
DiaMedica Therapeutics Inc. | DMAC | Pauls Dietrich John President and CEO |
5,000 | $3.14 | $15,700 | 35,804 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2024-06-01 Option Award |
2024-06-03 4:41 pm |
N/A 2034-05-31 |
DiaMedica Therapeutics Inc. | DMAC | Pauls Dietrich John President and CEO |
300,000 | $0 | 368,591 (Direct) |
View |
| 2023-06-01 Option Award |
2023-06-02 4:39 pm |
N/A 2033-05-31 |
DiaMedica Therapeutics Inc. | DMAC | Pauls Dietrich John President and CEO |
181,000 | $0 | 236,804 (Direct) |
View |
| 2022-06-01 Option Award |
2022-06-02 5:06 pm |
N/A 2032-05-31 |
DiaMedica Therapeutics Inc. | DMAC | Pauls Dietrich John President and CEO |
177,000 | $0 | 212,804 (Direct) |
View |
| 2021-07-28 Option Award |
2021-07-29 9:07 pm |
N/A 2031-07-27 |
DiaMedica Therapeutics Inc. | DMAC | Pauls Dietrich John President and CEO |
175,000 | $0 | 205,804 (Direct) |
View |
| 2020-06-01 Option Award |
2020-06-02 5:19 pm |
N/A 2030-05-31 |
DiaMedica Therapeutics Inc. | DMAC | Pauls Dietrich John President and CEO |
56,000 | $0 | 86,804 (Direct) |
View |